Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-09-03FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2010-09-03FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental application for Omeprazole and Sodium Bicarbonate.
-
FDA approval · 2010-09-03FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc., representing a labeling amen…
-
CLINICAL_TRIALS trial_result · 2010-09-01Clinical Trial Update: A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD) [Phase 2]
A Phase 2 study assessing tegaserod alone and in combination with omeprazole for symptomatic gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg [Phase 4]
Phase 4 trial comparing three proton-pump inhibitor regimens (rabeprazole 20 mg, esomeprazole 20 mg, and esomeprazole 40 mg) in gastroesopha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-08-23Clinical Trial Update: Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis
A completed clinical trial update evaluates proton pump inhibitor therapy for patients newly diagnosed with esophagitis, including erosive e…
-
CLINICAL_TRIALS trial_result · 2010-08-19Clinical Trial Update: Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI) [Phase 4]
This Phase 4 trial update reports the completion of a study evaluating pain modulation strategies in patients with gastroesophageal reflux d…
-
CLINICAL_TRIALS trial_result · 2010-08-19Clinical Trial Update: Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD. [Phase 2, Phase 3]
This document reports a completed Phase 2/3 trial evaluating pantoprazole 40 mg daily vs placebo in GERD, with outcomes based on power spect…
-
CLINICAL_TRIALS trial_result · 2010-08-19Clinical Trial Update: To Determine if Sleep Deprivation Results in Increased Esophageal Acid Exposure
A completed clinical trial evaluated whether sleep deprivation increases esophageal acid exposure in gastroesophageal reflux disease.
-
CLINICAL_TRIALS research · 2010-08-19Clinical Trial Update: Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD [Phase 2, Phase 3]
Update on a Phase 2/Phase 3 trial evaluating daily esomeprazole 40 mg for 7 days to treat acid reflux and sleep arousals in gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux [Phase 3]
Phase 3 trial evaluating lansoprazole for infants with gastroesophageal reflux symptoms has completed; sponsor Takeda.
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease [Phase 1]
Phase 1 study evaluating lansoprazole in hospitalized neonates with gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease. [Phase 1]
A Phase 1 clinical trial evaluating the effects of lansoprazole in infants with gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS research · 2010-07-22Clinical Trial Update: Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease
A completed clinical trial from UCSF examining the relationship and underlying mechanisms between gastroesophageal reflux and dental/periodo…
-
CLINICAL_TRIALS trial_result · 2010-07-21Clinical Trial Update: Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis [Phase 2]
Phase 2 trial comparing intravenous versus oral lansoprazole in patients with erosive esophagitis and gastroesophageal reflux disease to eva…
-
CLINICAL_TRIALS research · 2010-07-21Clinical Trial Update: The Effect of High PCO2 Solution on Esophageal Acid Sensation [NA]
A clinical trial update examines whether a high PCO2 solution affects esophageal acid sensation in gastroesophageal reflux disease. The curr…
-
FDA label_change · 2010-07-16FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a labeling supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen. The update m…
-
FDA approval · 2010-07-15FDA Approved: FAMOTIDINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for famotidine from Alembic Pharmaceuticals Inc., adding approved changes to the product under the A…
-
FDA approval · 2010-07-15FDA Approved: FAMOTIDINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for famotidine.
-
CLINICAL_TRIALS trial_result · 2010-07-13Clinical Trial Update: Effect of Coffee on Gastro-Esophageal Disease in Patients With Symptoms of Reflux [NA]
A completed clinical trial investigated the effect of coffee on gastroesophageal reflux disease symptoms in patients with reflux.
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal Symptoms
This clinical trial update reports the prevalence of gastroesophageal reflux disease among primary care patients with upper gastrointestinal…
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study [NA]
This document reports on a randomized, double-blind, placebo-controlled trial evaluating the use of high-dose proton pump inhibitors for gas…
-
CLINICAL_TRIALS research · 2010-07-07Clinical Trial Update: The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population [NA]
This clinical trial update discusses the use of a proton pump inhibitor to treat non-erosive gastroesophageal reflux disease in a Chinese po…
-
FDA approval · 2010-07-06FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
The FDA approved a supplemental application to market Prilosec OTC as an over-the-counter product containing omeprazole magnesium.
-
FDA approval · 2010-06-29FDA Approved: FAMOTIDINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for famotidine, a generic H2 blocker used for ulcers and GERD indications.